Alnylam Pharmace. buy HC Wainwright
Summary
This prediction is currently active. The prediction for Alnylam Pharmace. disappoints with a performance of -14.78%. This prediction currently runs until 07.08.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Alnylam Pharmace. | -1.647% | -1.647% |
iShares Core DAX® | -1.189% | -3.063% |
iShares Nasdaq 100 | 3.663% | 8.732% |
iShares Nikkei 225® | -1.422% | -0.414% |
iShares S&P 500 | 2.182% | 4.907% |
Comments by HC_Wainwright for this prediction
In the thread Alnylam Pharmace. diskutieren
Stopped prediction by HC_Wainwright for Alnylam Pharmace.
Alnylam Pharmace.
15.12.23
15.12.24
08:41
Alnylam Pharmace.
15.11.23
15.11.24
08:41
Alnylam Pharmace.
18.09.23
18.09.24
08:41
Alnylam Pharmace.
03.03.23
03.03.24
04.03.24